
Multiple sclerosis (MS) is a chronic, progressive, and disabling inflammatory neurologic condition that causes more disability than any other nontraumatic neurologic condition. Early diagnosis, treatment, and monitoring of disease progression are fundamental to optimizing management of patients with MS. Here, we present an online learning module that covers key principles in all phases of management, with a focus on up-to-date and evidence-based principles of providing high-quality care.
Course Credit:
1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
0.25 Pharmacology Hours
Dates:
Opens: 2022-08-25
Closes: 2023-08-25
Target Audience:
This activity was developed for neurologists, physician assistants, nurse practitioners, and allied healthcare professionals who diagnose and manage patients with multiple sclerosis (MS).
Supported by educational grants from Genentech, a member of the Roche Group, and Novartis.
Accreditation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 contact hour, including 0.25 pharmacology hours.
Additional Content Planners
Amber Lea Lambert, MSN, FNP-C, DNP (Nurse Reviewer)No significant relationships to disclose.
Kam A. Newman, MD (Peer Reviewer)
No significant relationships to disclose.
Sunali Wadehra, MD (Medical Writer)
No significant relationships to disclose.
Annenberg Center for Health Sciences
Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant financial relationships to disclose.
All of the financial relationships listed for these individuals have been mitigated.
-
Edward J. Fox, MD, PhD
Director, MS Clinic of Central Texas
Central Texas Neurology Consultants, PA
Clinical Associate Professor, University of Texas Dell Medical School
Round Rock, Texas -
Contributing Faculty
Matthew K. Schindler, MD, PhD
Assistant Professor of Neurology, MS Division
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Presenting Faculty
Downloads
Learning Objectives
- Select a treatment plan for a patient with MS that is consistent with the state-of-the-art in MS care
- Recognize a patient with a highly active MS presentation or a poor prognosis
- Select a treatment based on its demonstrated clinical efficacy and a patient’s MS presentation
- Recognize adverse event prevention, monitoring, and/or mitigation strategies
Faculty Disclosures
Edward J. Fox, MD, PhD
Advisory Board: Alexion, Biogen, Bristol Myers Squibb, Genentech, Horizon, Novartis
Consultant: Alexion, Biogen, Bristol Myers Squibb, Genentech, Horizon, Novartis
Speakers Bureau: Alexion, Biogen, Bristol Myers Squibb, Genentech, Horizon, Janssen, Sanofi Genzyme